8 - mar. - 2018
El miércoles 14 de marzo tendrá lugar la siguiente sesión del II Programa Progress Reports Valdecilla que contará con las ponencias de Javier Vázquez Bourgon y Leticia de las Vecillas Sánchez.
PONENTE: Javier Vázquez Bourgon
Título:"Searching for early biomarkers of long-term hepatic alterations in non-affective psychosis".
Javier Vázquez-Bourgon is assistant professor of Psychiatry and Consultant Psychiatrist at the Department of Medicine and Psychiatry, University of Cantabria, Santander.
He trained in Psychiatry at the Marques de Valdecilla University Hospital. During his training he carried out a 5-months training stage in the King´s College London, under the direction of Maria Jesús Arranz. After his clinical training he continued his research activity at IDIVAL and through a research fellowship at the Department of Psychological Medicine of the Institute of Psychiatry in London, UK.
He is currently a member of the research group in Non-Affective First Episode Psychosis of Cantabria (PAFIP) directed by Prof. Crespo-Facorro, and research collaborator of the research group CIBERSAM G26. His main areas of interest include the study the biological aspects of schizophrenia and neurocognitive deficits, clinical severity, treatment response and adverse effects occurrence (pharmacogenetics). And he has recently obtained a Next-Val 2017 and a Prim-Val 2017 grants (as PI and co-PI, respectively) for the study of the somatic health of patients with psychosis. Over the period 2005-2017, he has published 13 papers on MEDLINE in peer-reviewed psychiatric and neuroscience scientific journals, achieving a h factor 4.
PONENTE: Leticia de las Vecillas Sánchez
Título: “Drug hypersensitivity and desensitization: mechanisms and new approaches”
Leticia de las Vecillas is a clinician, researcher, and clinical assistant instructor at Marqués de Valdecilla University Hospital (HUMV) in Spain, where she completed her Allergy specialization in 2016.
She got a Wenceslao Lopez Albo scholarship (IDIVAL) to spend a year at the Drug Hypersensitivity and Desensitization center, directed by Mariana Castells MD, PhD at the Brigham and Women’s Hospital-Harvard Medical School (Boston, MA). While there she participated in the evaluation of more than 400 desensitizations to chemotherapy treatments, biological drugs, antibiotics, iron, hymenoptera venom immunotherapy, aspirin and others. She also worked in basic research with transgenes mouse mast cell to assess desensitization through the human IgE receptor FceRI using her in vitro model for desensitization. The projects focused on providing molecular target and characterizing the signal transduction involved in the desensitization.
Nowadays, she is an attending clinician at HUMV with adult and pediatric consultations and she is also in charge of the Drug Desensitizations at the HUMV.
Todas las sesiones tendrán lugar a las 14:00 en el Pabellón 16 del Hospital Universitario Marqués de Valdecilla (aforo máximo de 30 personas). La charla de cada ponente será de unos 20 minutos seguidos de un pequeño debate. Además, al finalizar se servirá un pequeño ágape para continuar con la conversación y fomentar la interacción entre los participantes y asistentes.
Se emitirán certificados de asistencia si se acude al 80% de las sesiones a lo largo del periodo académico, y se tendrá en cuenta la participación en los mismos dentro del programa de doctorado.
Cualquier duda o aclaración pueden ponerse en contacto en email@example.com